SK73998A3 - Compounds - Google Patents

Compounds Download PDF

Info

Publication number
SK73998A3
SK73998A3 SK739-98A SK73998A SK73998A3 SK 73998 A3 SK73998 A3 SK 73998A3 SK 73998 A SK73998 A SK 73998A SK 73998 A3 SK73998 A3 SK 73998A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
pyridyl
alkyl
optionally substituted
Prior art date
Application number
SK739-98A
Other languages
English (en)
Slovak (sk)
Inventor
David Cheshire
David Cladingboel
David Hardern
Michael Stocks
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9524920.7A external-priority patent/GB9524920D0/en
Priority claimed from GBGB9609403.2A external-priority patent/GB9609403D0/en
Priority claimed from GBGB9622412.6A external-priority patent/GB9622412D0/en
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of SK73998A3 publication Critical patent/SK73998A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SK739-98A 1995-12-06 1996-12-04 Compounds SK73998A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9524920.7A GB9524920D0 (en) 1995-12-06 1995-12-06 Compounds
GBGB9609403.2A GB9609403D0 (en) 1996-05-04 1996-05-04 Compounds
GBGB9622412.6A GB9622412D0 (en) 1996-10-22 1996-10-22 Compounds
PCT/SE1996/001595 WO1997020815A1 (en) 1995-12-06 1996-12-04 Compounds

Publications (1)

Publication Number Publication Date
SK73998A3 true SK73998A3 (en) 1999-02-11

Family

ID=27268017

Family Applications (1)

Application Number Title Priority Date Filing Date
SK739-98A SK73998A3 (en) 1995-12-06 1996-12-04 Compounds

Country Status (20)

Country Link
US (1) US5977105A (et)
EP (1) EP0865431A2 (et)
JP (1) JP2000501700A (et)
KR (1) KR19990071968A (et)
CN (1) CN1208403A (et)
AR (1) AR004893A1 (et)
AU (1) AU711772B2 (et)
BR (1) BR9611555A (et)
CZ (1) CZ172498A3 (et)
EE (1) EE9800172A (et)
HU (1) HUP9900143A3 (et)
IL (1) IL124768A0 (et)
IS (1) IS4739A (et)
MX (1) MX9804295A (et)
NO (1) NO982566L (et)
NZ (1) NZ323521A (et)
SA (1) SA97170633A (et)
SK (1) SK73998A3 (et)
TR (1) TR199801000T2 (et)
WO (1) WO1997020815A1 (et)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420375B1 (en) 1997-02-21 2002-07-16 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
WO1998042669A1 (en) * 1997-03-25 1998-10-01 Astra Pharmaceuticals Ltd. Novel pyridine derivatives and pharmaceutical compositions containing them
CA2284200A1 (en) * 1997-03-25 1998-10-01 Astra Pharmaceuticals Ltd. Novel pyridine derivatives and pharmaceutical compositions containing them
TR199902433T2 (xx) * 1997-04-01 2000-04-21 Astra Pharmaceuticals Ltd. Yeni piridin t�revleri ve bunlar� i�eren ispen�iyari bile�imler.
SE9803107D0 (sv) * 1998-09-14 1998-09-14 Astra Pharma Prod Novel Compunds
SE9803280D0 (sv) * 1998-09-25 1998-09-25 Astra Pharma Prod Novel compounds
SE9803277D0 (sv) * 1998-09-25 1998-09-25 Astra Pharma Prod Novel compounds
SE9803279D0 (sv) * 1998-09-25 1998-09-25 Astra Pharma Prod Novel compounds
US6307049B1 (en) * 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
JP2002534414A (ja) * 1999-01-08 2002-10-15 バーテックス ファーマシューティカルズ インコーポレイテッド 医薬の製造に有用な中間体の形成方法
SE9901079D0 (sv) * 1999-03-23 1999-03-23 Astra Ab Novel compounds
CA2314458A1 (en) * 1999-08-02 2001-02-02 Kazumi Okuro Process for production of 3-(3-pyridyl)-1-propanol derivatives
US6376524B1 (en) 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
GB0321538D0 (en) * 2003-09-13 2003-10-15 Glaxo Group Ltd Therapeutically useful compounds
WO2008060799A2 (en) * 2006-11-09 2008-05-22 Bausch & Lomb Incorporated Synthesis of selected stereoisomers of certain substituted alcohols
ES2601856T3 (es) 2007-06-08 2017-02-16 Mannkind Corporation Inhibidores de la IRE-1A

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0267439A3 (en) * 1986-10-14 1988-08-31 G.D. Searle & Co. Alpha-(phenylalkyl) pyridinealkanol derivatives
AU7975887A (en) * 1986-10-16 1988-04-21 G.D. Searle & Co. Alpha-((phenylmethoxy)methyl)pyridine alkanols
WO1990012006A1 (en) * 1989-04-07 1990-10-18 Pfizer Inc. Substituted 1-[3-(heteroarylmethoxy)phenyl]alkanols and related compounds in the treatment of asthma, arthritis and related diseases

Also Published As

Publication number Publication date
AR004893A1 (es) 1999-03-10
AU1048097A (en) 1997-06-27
IL124768A0 (en) 1999-11-30
NZ323521A (en) 1999-10-28
NO982566L (no) 1998-07-24
HUP9900143A2 (hu) 1999-05-28
EE9800172A (et) 1998-12-15
EP0865431A2 (en) 1998-09-23
US5977105A (en) 1999-11-02
KR19990071968A (ko) 1999-09-27
NO982566D0 (no) 1998-06-04
IS4739A (is) 1998-05-12
AU711772B2 (en) 1999-10-21
HUP9900143A3 (en) 2000-04-28
SA97170633A (ar) 2005-12-03
BR9611555A (pt) 1999-03-02
CZ172498A3 (cs) 1998-12-16
JP2000501700A (ja) 2000-02-15
TR199801000T2 (xx) 1998-08-21
MX9804295A (es) 1998-09-30
CN1208403A (zh) 1999-02-17
WO1997020815A1 (en) 1997-06-12

Similar Documents

Publication Publication Date Title
SK73998A3 (en) Compounds
FI86169C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva fenyl-, pyridyl-, kinolyn- eller tienylsubstituerade alken-, alkyn- eller cykloalkylenderivat.
US20060025474A1 (en) Bisphenyl compounds useful as vitamin D3 receptor agonists
JPS6118747A (ja) (アシルオキシアルキル)カルボネート誘導体及びその製造方法
WO2005044780A1 (ja) アミノカルボン酸誘導体とその付加塩及びs1p受容体調節剤
US5541203A (en) Triazole antifungal agents
DE3431004A1 (de) Neue 3-pyridylverbindungen und verfahren zu ihrer herstellung
JPH0717634B2 (ja) トリ‐およびテトラ‐置換‐オキセタンおよびテトラヒドロフランおよびその中間体
US6300352B1 (en) Pyridine derivatives and pharmaceutical compositions containing them
AP333A (en) Phenyl-substituted pyridyl aliphatic compounds for treating leukotriene-related diseases.
DE69209099T2 (de) Sulfonamidderivate
US5254549A (en) New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
JP3053428B2 (ja) 抗炎症活性を有するピリジルフェニル窒素複素環―置換カルビノールおよびその誘導体
US6143751A (en) Pyridine derivatives and pharmaceutical compositions containing them
EP2164825B1 (en) Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
JPS606653A (ja) 抗高コレステロ−ル血症活性を有する5−チアアルカン酸誘導体
AU6236799A (en) Novel compounds
CA2237478A1 (en) Compounds
DE68922038T2 (de) Antiinflammatorische Carbinolimidazole.
CZ343699A3 (cs) Nové pyridinové deriváty a farmaceutické prostředky s jejich obsahem
MXPA99008489A (en) Novel pyridine derivatives and pharmaceutical compositions containing them
MXPA01002293A (en) Novel compounds
LV10423B (en) New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
JP2006347882A (ja) ベンジルアルコール誘導体又はその塩
WO1992017172A1 (en) Disubstituted naphthalenes